328 related articles for article (PubMed ID: 19787202)
1. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
2. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
Kopp R; Fichter M; Assert R; Pfeiffer AF; Classen S
Int J Mol Med; 2009 May; 23(5):639-49. PubMed ID: 19360323
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
[TBL] [Abstract][Full Text] [Related]
4. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
Gorham H; Sugino T; Woodman AC; Tarin D
J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
[TBL] [Abstract][Full Text] [Related]
5. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
7. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues.
Higashikawa K; Yokozaki H; Ue T; Taniyama K; Ishikawa T; Tarin D; Tahara E
Int J Cancer; 1996 Mar; 66(1):11-7. PubMed ID: 8608952
[TBL] [Abstract][Full Text] [Related]
10. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
11. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
12. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
Yu Q; Toole BP
J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
[TBL] [Abstract][Full Text] [Related]
13. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
16. Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells.
Gu J; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
Pathol Int; 1998 Mar; 48(3):184-90. PubMed ID: 9589486
[TBL] [Abstract][Full Text] [Related]
17. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CD44v3-containing isoforms in head and neck cancer.
Reategui EP; de Mayolo AA; Das PM; Astor FC; Singal R; Hamilton KL; Goodwin WJ; Carraway KL; Franzmann EJ
Cancer Biol Ther; 2006 Sep; 5(9):1163-8. PubMed ID: 16855392
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
